Portfolio - Ambria Capital

Psychedelics
Now

We see a new paradigm ripe with
treatments that will set people free.

Our current investment focus is on psychedelic therapies and technologies, where world-class innovators are driving the future of mental healthcare by:

Broadening affordability and access to highly effective psychedelic therapies
Researching breakthrough medicines for a range of mental health conditions
Enhancing the quality and accuracy of diagnoses and treatments
Combining technology and biology to accelerate therapeutic development
Disrupting the current mental health market by rethinking the familiar to offer hope to millions

If your company is early stage, pre-Series A, and working to solve our generation’s greatest challenges, we want to talk with you. We appreciate the chance to partner with disrupters and offer a nurturing, collaborative environment where a burning desire to advance human development is the top priority.

Psychedelics

Technology